The landscape of managing diabetes is evolving with the arrival of skin-applied GLP-1 therapy. These innovative devices offer a likely simpler alternative to needle administrations for individuals living with type 2 diabetes . They deliver glucagon-like peptide-1 directly through the epidermis, avoiding the requirement for regular injections and pe